Swedish healthcare group Asker Healthcare Group AB (STO: ASKER), which provides medical products and solutions across Europe, said on Tuesday it has acquired 100% of the shares in Teresa OÜ, an Estonian supplier of mobility aids and personal assistive equipment.
Teresa sells and rents mobility aids, personal care products and medical devices to patients and care providers through 11 service centres across Estonia and an online platform. The company employs 26 people and generated approximately SEK41m in revenue over the past year.
Asker Healthcare Group said Teresa's locations and product range complement its existing presence in Estonia and expand its ability to support patients and professional care providers.
The acquisition is expected to have a positive impact on the group's EBITA margin.
Vivesto secures US orphan drug designation for Cantrixil in acute myeloid leukemia
Lytix Biopharma's ruxotemitide combination meets primary endpoint in Phase II melanoma trial
Asker Healthcare Group acquires Estonia's Teresa OÜ
Roche wins FDA clearance for customisable respiratory pathogen test
Abbott's Amulet 360 shows high LAA closure rates and low stroke incidence at one year
INOVIO's VOCERYQ receives US FDA accelerated approval to reduce surgery frequency in adults with RRP
Abbott reports 30-day results from clinical trial of SonicForce Coronary IVL System
Bambusa Therapeutics prices upsized initial public offering
Phrontline Biopharma reports preliminary safety and antitumour activity for TJ101
Daiichi Sankyo secures EMA validation for two triple-combination cholesterol therapies
TME Pharma signs exclusive negotiation agreement with Japan's TMS for NOX-A12 rights
Ascletis reports positive US Phase II topline results for ASC30 in diabetes
Evogene targets acute graft-versus-host disease for AI-driven drug discovery programme
Genmab reports 50% reduction in risk of death in Phase 3 head and neck cancer trial
Novocure and Verastem to evaluate combination therapy for pancreatic cancer